Real-time · AI · Cross-signal
Benchling just moved. Here's exactly what to do next.
Who to reach, what to say, and why now — on Benchling, plus every launch, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Benchling launched Benchling Biologics, a no-code platform for antibody R&D that enables rapid configuration and registration of antibodies.
May 11, 2026•28 days ago
Product Description
At the PEGS Boston Summit, Benchling announced Benchling Biologics, an end-to-end platform designed to streamline the process of antibody R&D with no-code configuration and automated registration capabilities.
Related People
Suggested for you
Product Launch Insights
Based on market dataMarket expansion signals
New product launches often coincide with market expansion initiatives
Fresh market entry
Products launched in the last 30 days have highest engagement rates